Indischer Weihrauch (Salai guggal) bei rheumatoider Arthritis und Osteoarthritis

Zusammenfassung

Die Anwendung von Extrakten aus dem indischen Weihrauch bei rheumatischen Erkrankungen ist derzeit in Deutschland weitverbreitet. In Tierversuchen wurde eine antiphlogistische/antirheumatische Wirkung dieses Extraktes beschrieben. Bisherige klinische Studien sprechen dafür, dass sich Extrakte aus dem Gummiharz von Boswellia serrata günstig bei rheumatoider Arthritis sowie bei Osteoarthritis auswirken. Allerdings sind die erhobenen Fallzahlen gering und eine Reihe von Studien leidet unter Mängeln. Da Extrakte aus dem indischen Weihrauch arm an Nebenwirkungen sind, sollten klinische Studien gemäß wissenschaftlichem Standard durchgeführt werden, um Sicherheit, Wirksamkeit und Verträglichkeit zu beweisen.

Summary

Indian incense (Salai guggal) for the treatment of rheumatoid arthritis and osteoarthritis Extracts from the gum resin of Boswellia serrata (BSE) have been reported to posses antiphlogistic and antirheumatic effects in animal experiments. These effects are thought to be due to so-called boswellic acids. Boswellic acids have been reported to inhibit factors which are related to the immune system. Clinical studies so far show that BSE have beneficial effects on rheumatoid arthritis and osteoarthritis. Nevertheless the studies have only small numbers of patients and some of the studies have not been carried out according to the present scientific rules. On the other hand, since BSE have only little side effects and the diseases in question are mostly chronic and are treated with drugs possessing a number of adverse effects, further clinical studies with high scientific standards are necessary to finally prove their efficacy and safety.

Schlüsselwörter

Weihrauch - Boswellia serrata - Rheuma - Arthritis - Osteoarthritis

Key words

Incense - Boswellia serrata - rheumatism - arthritis - osteoarthritis - clinical studies

Literatur

• 1 Ammon HP. Boswellic acids in chronic inflammatory diseases.  Planta Med. 2006;  72 1100-1116
• 2 Etzel R. Special extract of Boswellia serrata (H15) in the treatment of rheumatoid arthritis.  Phytomedicine. 1996;  3 91-94
• 3 Fan AY, Lao L, Zhang RX, et al.. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation.  J Altern Complement Med. 2005;  11 323-331
• 4 Gupta OP, Sharma N, Chand D. A sensitive and relevant model for evaluating anti-inflammatory activity – papaya latex-induced rat paw inflammation.  J Pharmacol Toxicol Methods. 1992;  28 15-19
• 5 Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomised double blind placebo controlled trial.  Phytomedicine. 2003;  10 3-7
• 6 Safayhi H, Mack T, Sabieraj J, et al.. Boswellic acids: novel, specific nonredox inhibitors of 5-lipoxygenase.  J Pharmacol Exp Ther. 1992;  261 1143-1146
• 7 Sander O, Herborn G, Rau R. Is H15 (extract of Boswellia serrata, “incense”) an efficient supplementation to established drug therapy of rheumatoid arthritis? Results of a double-blind pilot trial.  Z Rheumatol. 1998;  57 11-16
• 8 Sengupta K, Alluri KV, Satish AR, et al.. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin^® for treatment of osteoarthritis of the knee.  Arthritis Res Ther. 2008;  10 R85
• 9 Singh GB, Atal CK. Pharmacology of an extract of salai guggal ex Boswellia serrata, a new non-steroidal anti-inflammatory agent.  Agents Actions. 1986;  18 407-412
• 10 Sontakke S, Thawani V, Pimpalkhute S, et al.. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee.  Indian J Pharmacol. 2007;  39 27-29